160 related articles for article (PubMed ID: 8704607)
1. [The clinical efficacy of taufon in the combined treatment of patients with chronic circulatory failure].
Zavolovskaia LI; Elizarova EP; Orlov VA
Eksp Klin Farmakol; 1995; 58(6):29-32. PubMed ID: 8704607
[TBL] [Abstract][Full Text] [Related]
2. [The angiotensin-converting enzyme inhibitor perindopril in the treatment of congestive heart failure].
Tereshchenko SN; Drozdov VN; Demidova IV; Levchuk NN; Moiseev VS
Ter Arkh; 1997; 69(7):53-6. PubMed ID: 9424761
[TBL] [Abstract][Full Text] [Related]
3. [The use of ramipril in treating patients with chronic heart failure].
Sinitsina II; Orlov VA; Zakharova GIu; Giliarevskiĭ SR; Ivasenko LA
Ter Arkh; 1995; 67(5):75-7. PubMed ID: 7638788
[No Abstract] [Full Text] [Related]
4. [Gopten (trandolapril) in the treatment of chronic heart failure in patients with ischemic heart disease].
Kakhnovskiĭ IM; Fomina IG; Ostroumov EL; Lepeshkov VM; Gaĭdamakina NE; Kaveshnikova OV; Markova ZS; Lugovaia EL
Ter Arkh; 1998; 70(8):29-33. PubMed ID: 9770740
[TBL] [Abstract][Full Text] [Related]
5. [Effect of a compound preparation pumpan on exercise tolerance and clinical course of ischemic heart disease].
Krasnitskiĭ VB; Aronov DM; Zhidko NI
Ter Arkh; 2003; 75(8):17-21. PubMed ID: 14520844
[TBL] [Abstract][Full Text] [Related]
6. [Essential phospholipids in combined therapy of chronic circulatory insufficiency].
Golochevskaia VS; Baranskaia EK; Trofimenko IV; Balakhonova NP; Burmakin IA; Kop'ev VI; Zadorozhnaia OO
Klin Med (Mosk); 1997; 75(5):30-3. PubMed ID: 9235405
[TBL] [Abstract][Full Text] [Related]
7. [The treatment of chronic left ventricular insufficiency].
Castaigne A; Dubois-Randé JL; Duval-Moulin AM; Merlet P; Saal JP; Perchet H; Dutoit C
Rev Prat; 1990 Oct; 40(23 Suppl):37-42. PubMed ID: 2267564
[TBL] [Abstract][Full Text] [Related]
8. [Influence of medical treatments on the functional status in patients with chronic cardiac insufficiency].
Cohen-Solal A; Laperche T; Gourgon R
Arch Mal Coeur Vaiss; 1990 Nov; 83(13):1953-5. PubMed ID: 2125415
[TBL] [Abstract][Full Text] [Related]
9. [Effectiveness of long-term ACE-inhibition on pulmonary diffusion and ventilation-perfusion ratio in chronic heart failure: correlation with physical performance].
Guazzi M; Pontone G; Trevisi N; Lomanto M; Melzi G; Agostoni P
Ann Ital Med Int; 1998; 13(1):17-23. PubMed ID: 9642838
[TBL] [Abstract][Full Text] [Related]
10. Cardio-renal effects of the A1 adenosine receptor antagonist SLV320 in patients with heart failure.
Mitrovic V; Seferovic P; Dodic S; Krotin M; Neskovic A; Dickstein K; de Voogd H; Böcker C; Ziegler D; Godes M; Nakov R; Essers H; Verboom C; Hocher B
Circ Heart Fail; 2009 Nov; 2(6):523-31. PubMed ID: 19919976
[TBL] [Abstract][Full Text] [Related]
11. [The use of mildronat in heart failure in patients with chronic ischemic heart disease].
Sakharchuk II; Denisenko GT; Grushko VS; Bodaretskaia OI; Pishchalenko AN
Vrach Delo; 1989 Sep; (9):21-3. PubMed ID: 2609613
[TBL] [Abstract][Full Text] [Related]
12. [Effect of the alpha-adrenoblockader fentolamin on the indices of central and peripheral hemodynamics and myocardial contractile function in patients with chronic circulatory failure].
Aminov VN; Zamochnikova NI
Ter Arkh; 1984; 56(5):101-5. PubMed ID: 6463875
[No Abstract] [Full Text] [Related]
13. [Characteristics of the action of strophanthin on central hemodynamics, pulmonary and intrahepatic blood circulation and myocardial contraction].
Zavolovskaia LI
Ter Arkh; 1985; 57(3):115-7. PubMed ID: 4002150
[TBL] [Abstract][Full Text] [Related]
14. Short-term improvement in submaximal exercise capacity by optimized therapy with ACE inhibitors and beta blockers in heart failure patients is associated with restoration of peripheral endothelial function.
Poelzl G; Frick M; Lackner B; Huegel H; Alber HF; Mair J; Herold M; Schwarzacher SP; Pachinger O; Weidinger F
Int J Cardiol; 2006 Mar; 108(1):48-54. PubMed ID: 16516697
[TBL] [Abstract][Full Text] [Related]
15. [Nicotinic acid in the treatment of chronic circulatory failure in patients with ischemic heart disease].
Kats GL; Zhivotovskaia IA; Gnilitskaia VB; Alifanova RE; Mal'tseva NV
Vrach Delo; 1989 Sep; (9):16-9. PubMed ID: 2609611
[TBL] [Abstract][Full Text] [Related]
16. [The optimization of the hemodynamic characteristics in patients with ischemic heart disease and circulatory failure by using a substrate-coenzyme complex].
Vizir AD; Dunaev VV; Berezin AE; Kraĭdashenko OV
Lik Sprava; 1997; (5):53-6. PubMed ID: 9491697
[TBL] [Abstract][Full Text] [Related]
17. Functional improvement in heart failure patients treated with beta-blockers is associated with a decline of cytokine levels.
Mayer B; Holmer SR; Hengstenberg C; Lieb W; Pfeifer M; Schunkert H
Int J Cardiol; 2005 Aug; 103(2):182-6. PubMed ID: 16080978
[TBL] [Abstract][Full Text] [Related]
18. Effects of cardiac resynchronization on disease progression in patients with left ventricular systolic dysfunction, an indication for an implantable cardioverter-defibrillator, and mildly symptomatic chronic heart failure.
Abraham WT; Young JB; León AR; Adler S; Bank AJ; Hall SA; Lieberman R; Liem LB; O'Connell JB; Schroeder JS; Wheelan KR;
Circulation; 2004 Nov; 110(18):2864-8. PubMed ID: 15505095
[TBL] [Abstract][Full Text] [Related]
19. [Physical rehabilitation in the complex hospital therapy of patients with chronic low cardiac output].
Efremushkin GG; Antropova ON; Osipova IV
Ter Arkh; 2003; 75(12):50-4. PubMed ID: 14959471
[TBL] [Abstract][Full Text] [Related]
20. Drugs for treatment of chronic heart failure.
Treat Guidel Med Lett; 2009 Jul; 7(83):53-6. PubMed ID: 19556942
[No Abstract] [Full Text] [Related]
[Next] [New Search]